People · Operator
Named in public records as an officer, director or promoter · active 2009–2021 · Other, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Bioformix Inc. | — | Other | Series A | $47.0M | $75.7M | 2011 |
| Novomer Inc | — | Other Technology | Series B | $33.0M | $456.8M | 2009 |
| Conamix Inc. | — | Other Technology | Seed | $12.7M | $6.2M | 2018 |
Robert Pangborn at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert Pangborn on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Smith | 1 | 17 |
| Carl Weissman | 1 | 8 |
| John Trbovich | 1 | 7 |
| William Lese | 1 | 6 |
| Andrew Williamson | 1 | 6 |
| Doug Cameron | 1 | 5 |
| John Habbert | 1 | 5 |
| David Schroeder | 1 | 5 |
| Saif Qazi | 1 | 4 |
| Adam Malofsky | 1 | 3 |
| Charles Hamilton | 1 | 3 |
| James Mahoney | 1 | 2 |
| Jeffrey Chamberlain | 1 | 2 |
| Scott D. Allen | 1 | 1 |
| Cory D. Steffek | 1 | 1 |
| Tony D. Eisenhut | 1 | 1 |
| Peter Shepard | 1 | 1 |
| Ron Valente | 1 | 1 |
| Carl D. Weissman | 1 | 1 |
| James D. Matheson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.